Pierotti, A R <br/><br/>
High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome.  [electronic resource] 

 -  Neuroscience letters  Jan 1986 
 - 141-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0304-3940 
<br/><br/><label>Standard No.: </label>10.1016/0304-3940(86)90051-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Alzheimer Disease--metabolism<br/>Choline O-Acetyltransferase--metabolism<br/>Down Syndrome--metabolism<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Molecular Weight<br/>Peptides--analysis<br/>Somatostatin--analysis<br/>Somatostatin-28<br/>Temporal Lobe--analysis